Healthcare provider profile · identity verified

Michelle Lee Ray, MD

Allopathic & Osteopathic Physicians|Internal Medicine · MARSHALL, TX · NPI 1184120735

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Michelle Lee Ray, MD received $92.18 in general payments during 2025 across 2 reported records.

Straumann USA LLC accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$92.18

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Straumann USA LLC	Unresolved — no canonical attribution shown	$92.18	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$92.18	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	407	118
Levothyroxine Sodium	Levothyroxine Sodium	300	75
Pantoprazole Sodium	Pantoprazole Sodium	300	95
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	274	48
Amlodipine Besylate	Amlodipine Besylate	273	89
Lisinopril	Lisinopril	202	62
Rosuvastatin Calcium	Rosuvastatin Calcium	182	49
Furosemide	Furosemide	152	44
Meloxicam	Meloxicam	151	50
Gabapentin	Gabapentin	145	53
Tramadol Hcl	Tramadol Hcl	144	40
Duloxetine Hcl	Duloxetine Hcl	139	41
Losartan Potassium	Losartan Potassium	135	40
Olmesartan Medoxomil	Olmesartan Medoxomil	126	34
Omeprazole	Omeprazole	126	40
Acetaminophen-Codeine	Acetaminophen With Codeine	122	27
Albuterol Sulfate Hfa	Albuterol Sulfate	119	38
Montelukast Sodium	Montelukast Sodium	119	37
Hydrochlorothiazide	Hydrochlorothiazide	113	38
Trazodone Hcl	Trazodone Hcl	106	39
Carvedilol	Carvedilol	104	32
Metformin Hcl	Metformin Hcl	99	30
Potassium Chloride	Potassium Chloride	98	32
Sertraline Hcl	Sertraline Hcl	97	31
Ozempic	Semaglutide	92	26
Buspirone Hcl	Buspirone Hcl	91	23
Azithromycin	Azithromycin	89	73
Metoprolol Succinate	Metoprolol Succinate	89	29
Simvastatin	Simvastatin	87	26
Pregabalin	Pregabalin	80	25
Metformin Hcl Er	Metformin Hcl	79	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	29
Clopidogrel	Clopidogrel Bisulfate	74	26
Tamsulosin Hcl	Tamsulosin Hcl	72	25
Metoprolol Tartrate	Metoprolol Tartrate	69	24
Bupropion Xl	Bupropion Hcl	67	23
Eliquis	Apixaban	64	18
Alprazolam	Alprazolam	61	15
Methocarbamol	Methocarbamol	59	21
Glimepiride	Glimepiride	57	18
Oxybutynin Chloride Er	Oxybutynin Chloride	57	18
Escitalopram Oxalate	Escitalopram Oxalate	54	15
Amitriptyline Hcl	Amitriptyline Hcl	51	18
Farxiga	Dapagliflozin Propanediol	51	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	42
Ezetimibe	Ezetimibe	49	16
Tizanidine Hcl	Tizanidine Hcl	47	19
Famotidine	Famotidine	46	19
Pravastatin Sodium	Pravastatin Sodium	46	13
Jardiance	Empagliflozin	45	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	44	suppressed
Spironolactone	Spironolactone	44	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	12
Mirtazapine	Mirtazapine	43	17
Temazepam	Temazepam	43	12
Citalopram Hbr	Citalopram Hydrobromide	42	13
Diclofenac Sodium	Diclofenac Sodium	42	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	11
Prednisone	Prednisone	41	29
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Nifedipine Er	Nifedipine	40	13
Ondansetron Odt	Ondansetron	39	14
Ventolin Hfa	Albuterol Sulfate	39	12
Alendronate Sodium	Alendronate Sodium	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	12
Fluticasone Propionate	Fluticasone Propionate	36	14
Pioglitazone Hcl	Pioglitazone Hcl	36	12
Memantine Hcl	Memantine Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Topiramate	Topiramate	34	11
Clonazepam	Clonazepam	32	suppressed
Estradiol	Estradiol	32	11
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Nystatin	Nystatin	31	14
Cefdinir	Cefdinir	29	24
Celecoxib	Celecoxib	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Lidocaine	Lidocaine	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	16
Acyclovir	Acyclovir	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Diazepam	Diazepam	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	15
Fluconazole	Fluconazole	22	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	15
Terbinafine Hcl	Terbinafine Hcl	22	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Cephalexin	Cephalexin	20	11
Colesevelam Hcl	Colesevelam Hcl	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Linzess	Linaclotide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Febuxostat	Febuxostat	18	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lactulose	Lactulose	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Torsemide	Torsemide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Metolazone	Metolazone	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Ramipril	Ramipril	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Finasteride	Finasteride	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$92.18 · 2 records	Straumann USA LLC	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error